Laskowska in 2017, tested the hypothesis that maternal serum matrix metalloproteinases-2, -3, -9, and -13 levels could differ in early- and late-onset preeclampsia and uncomplicated pregnancies. The gene discussed is MMP2; the disease is preeclampsia.